AKR1B10 and hepatocellular carcinoma: Aldo-keto reductase family 1 member B10 (AKR1B10) also operates as an oncogene in HCC; so, in HCC cells, AKR1B10 silencing inhibited cell proliferation (Wang et al., 2018a).